南美超级胎牛血清999尝鲜特惠
转染试剂低至5折
基质胶阶梯特惠
积分商城,好礼送不停
南美超级胎牛血清999尝鲜特惠
转染试剂低至5折
基质胶阶梯特惠
积分商城,好礼送不停
分子生物学
IVD分子诊断
细胞培养与分析
蛋白研究
细胞因子
重组蛋白
抗体
高通量测序建库
病原检测UCF系列
生物医药
工具酶
抑制剂激活剂与常用试剂
仪器
耗材

体内CRISPR筛选技术揭示DNMT3A在介导肿瘤免疫逃逸中的双重功能

In vivo CRISPR screens identify dual functions of DNMT3A in mediating tumor immune evasion

Zhao Jianhong, Deng Yanrong, Chen Haonan, Zhou Xiaojun, Yin Siyuan, Qian Qun, Xie Xiaoyu, Chen Quanjiao, Zhang Jinfang, Fan Lifang, Ren Xianghai, Chen Baoxiang, Jiang Congqing

Journal:Nature Communications

IF:18.1

DOI:10.1038/s41467-026-77495-z

PMID:42864360

Published:2026-09-11

research field:肿瘤学毒理学生物医学工程药学呼吸生物学纳米技术癌症治疗生物化学

Abstract

Cancer immunotherapy has achieved remarkable clinical efficacy across multiple cancers but remains ineffective for most patients, and the mechanisms underlying resistance remain incompletely understood. Here, we perform in vivo CRISPR-Cas9 screens in female mice and identify DNA methyltransferase 3 A (DNMT3A) as a key driver of tumor immune evasion through both methyltransferase-dependent and -independent mechanisms. DNMT3A represses TNFRSF1A and TNFRSF1B expression, enabling tumor cells to evade TNFα-induced killing. Independently of its methyltransferase activity, DNMT3A interacts with NFYA to activate cholesterol biosynthesis, leading to zymosterol accumulation in tumor interstitial fluid. Zymosterol impairs SREBP2 cleavage and promotes HMGCR degradation in CD8⁺ T cells, thereby suppressing cholesterol biosynthesis and compromising their antitumor effector functions. Targeting DNMT3A with antisense oligonucleotides overcomes resistance to immune checkpoint blockade. Collectively, these findings establish DNMT3A as an integrated epigenetic and metabolic checkpoint in tumor immune evasion and a potential target for immunotherapy.

本文使用的Yeasen产品

购物车
客服
转染试用